Historical record - last NADAC effective date: 9/18/2024
Product Information
CLOTRIMAZOLE-BETAMETHASONE CRM is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2498 per GM under NDC 68462029817. Its NADAC has been published 453 times since Feb 3, 2016.
FDA first approved this application on Oct 30, 2015.
Strength
.5; 10 mg/g; mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462029817
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/18/2024
Active Ingredients
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202894FDA Approved
10/30/2015
On Market Since
11/6/2015
Pharmacological Classes
Price Statistics
The NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has been published 453 times since Feb 3, 2016, and over the history we have for it it has declined 72.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2498 per GM |
|---|---|
| All-time high | $0.9048 (Feb 10, 2016) |
| All-time low | $0.1931 (May 22, 2024) |
| Median price | $0.3127 |
| Average price | $0.3629 |
| Largest weekly change | +37.7% (Dec 23, 2020) |
| Weeks tracked | 453 |
| Tracking since | Feb 3, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+12.5%
5Y
-0.1%
All
-72.4%
Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clotrimazole and Betamethasone Dipropionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOTRIMAZOLE-BETAMETHASONE CRM?
The current National Average Drug Acquisition Cost (NADAC) for CLOTRIMAZOLE-BETAMETHASONE CRM, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2498 per GM (NDC 68462029817), effective Oct 2, 2024.
How has the price of CLOTRIMAZOLE-BETAMETHASONE CRM changed over time?
Over the history we have for it, the NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has declined 72.4%. It has been tracked across 453 weekly CMS publications since Feb 3, 2016.
What are the highest and lowest recorded NADAC prices for CLOTRIMAZOLE-BETAMETHASONE CRM?
Since Feb 3, 2016, the NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has ranged from a low of $0.1931 (May 22, 2024) to a high of $0.9048 (Feb 10, 2016), with a median of $0.3127 per GM.
Are there cheaper alternatives to CLOTRIMAZOLE-BETAMETHASONE CRM?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOTRIMAZOLE-BETAMETHASONE CRM, is $0.1781 per GM — about 29% below CLOTRIMAZOLE-BETAMETHASONE CRM.
Who manufactures CLOTRIMAZOLE-BETAMETHASONE CRM?
CLOTRIMAZOLE-BETAMETHASONE CRM (NDC 68462029817) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.